NO912804L - Purine derivatives. - Google Patents

Purine derivatives.

Info

Publication number
NO912804L
NO912804L NO91912804A NO912804A NO912804L NO 912804 L NO912804 L NO 912804L NO 91912804 A NO91912804 A NO 91912804A NO 912804 A NO912804 A NO 912804A NO 912804 L NO912804 L NO 912804L
Authority
NO
Norway
Prior art keywords
purine derivatives
purine
derivatives
Prior art date
Application number
NO91912804A
Other languages
Norwegian (no)
Other versions
NO912804D0 (en
Inventor
Roland Jaunin
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO912804D0 publication Critical patent/NO912804D0/en
Publication of NO912804L publication Critical patent/NO912804L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO91912804A 1990-07-18 1991-07-17 Purine derivatives. NO912804L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH238790 1990-07-18

Publications (2)

Publication Number Publication Date
NO912804D0 NO912804D0 (en) 1991-07-17
NO912804L true NO912804L (en) 1992-01-20

Family

ID=4232597

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91912804A NO912804L (en) 1990-07-18 1991-07-17 Purine derivatives.

Country Status (13)

Country Link
EP (1) EP0467207A3 (en)
JP (1) JPH04234391A (en)
KR (1) KR920002600A (en)
AU (1) AU8038491A (en)
CA (1) CA2044806A1 (en)
FI (1) FI913407A (en)
HU (1) HU209591B (en)
IE (1) IE912500A1 (en)
IL (1) IL98812A0 (en)
MC (1) MC2278A1 (en)
NO (1) NO912804L (en)
PT (1) PT98348A (en)
ZA (1) ZA915418B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE70593B1 (en) * 1989-09-29 1996-12-11 Eisai Co Ltd Biphenylmethane derivative the use of it and pharmacological compositions containing same
US5202328A (en) * 1991-03-06 1993-04-13 Merck & Co., Inc. Substituted fused pyrimidinones
TW274551B (en) * 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd
SE9903028D0 (en) 1999-08-27 1999-08-27 Astra Ab New use
PE20030008A1 (en) 2001-06-19 2003-01-22 Bristol Myers Squibb Co DUAL INHIBITORS OF PDE 7 AND PDE 4
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA3089569C (en) 2007-06-04 2023-12-05 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP2016514670A (en) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド Guanylate cyclase receptor agonists in combination with other drugs
RS65632B1 (en) 2013-06-05 2024-07-31 Bausch Health Ireland Ltd Ultra-pure agonists of guanylate cyclase c, method of making and using same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US5015651A (en) * 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc Di-substituted imidazo fused 6-membered nitrogen-containing heterocycles and pharmaceutical compositions containing them
IL96019A0 (en) * 1989-10-31 1991-07-18 Fujisawa Pharmaceutical Co Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
EP0430300A3 (en) * 1989-12-01 1992-03-25 Takeda Chemical Industries, Ltd. Xanthine derivatives, their production and use

Also Published As

Publication number Publication date
EP0467207A3 (en) 1992-08-12
AU8038491A (en) 1992-01-23
ZA915418B (en) 1992-03-25
KR920002600A (en) 1992-02-28
PT98348A (en) 1992-05-29
FI913407A0 (en) 1991-07-15
CA2044806A1 (en) 1992-01-19
EP0467207A2 (en) 1992-01-22
IL98812A0 (en) 1992-07-15
MC2278A1 (en) 1993-06-23
JPH04234391A (en) 1992-08-24
HU209591B (en) 1994-08-29
IE912500A1 (en) 1992-01-29
HU912347D0 (en) 1991-12-30
NO912804D0 (en) 1991-07-17
HUT58736A (en) 1992-03-30
FI913407A (en) 1992-01-19

Similar Documents

Publication Publication Date Title
NO910368D0 (en) Triazole DERIVATIVES.
NL300250I2 (en) Chinuclidine derivatives.
DE69110254D1 (en) Hydroxyquinolone derivatives.
DE69105856D1 (en) Acetamide derivatives.
FI900937A (en) ANORDNING FOER AXIALLAGRET I EN BORRMASKIN.
DE69110093D1 (en) Pyrimidine derivatives.
NO912804L (en) Purine derivatives.
FI900987A (en) ANORDNING I TRAEBEARBETNINGSMASKINER.
NO884830L (en) Purine DERIVATIVES.
DE59106761D1 (en) N-acylpyrrolidine derivatives.
FI913763A0 (en) FOERBAETTRINGAR TILL TOBAKSPRODUKTER.
FI910897A0 (en) FOERBAETTRINGAR ROERANDE (S) -NORFLUOXETIN.
FI912361A0 (en) KABLINGSMASKIN FOER S / Z-KABLING.
DE69004844D1 (en) Pyrimidine derivatives.
FI910654A (en) FOERVARINGS- OCH DISPENSERINGSANORDNING FOER TILL EN CYLINDRISK FOERPACKNING RULLADE FLEXIBLA PLASTPAOSAR.
FI901282A0 (en) MANTELKONSTRUKTION FOER PRESSPARTIET I EN PAPPERSMASKIN.
DE69109531D1 (en) 4-piperidinyl-ergoline derivatives.
FI901348A (en) MAETNINGSFOENSTER I MAETCELL.
DE69106651D1 (en) KS-505 derivatives.
MA21724A1 (en) FURANNE DERIVATIVES.
FI903707A0 (en) MONTERINGSKIL TILL EN ICKE-BAERANDE MELLANVAEGG.
FI901592A (en) SLIRSKYDD TILL GUMMIDAECK.
FI905045A0 (en) ANORDNING TILL BARNSAENG.
FI906231A0 (en) RAMANORDNING TILL ELEKTRISK BASTUUGN.
FI902184A (en) STAENKSKYDD TILL FORDON.